Celyad Oncology

Celyad Oncology

Foundation date

24/07/2007

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Cell therapy
• #Therapeutics - Proteins
• #Therapeutics - Stem cells

Therapeutic areas

• #Cardiovascular
• #Neoplasms / cancer / oncology

Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of CAR T therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs. For more information, please visit www.celyad.com.